Cabaletta Bio

Home » Cabaletta Bio

IPO

Cabaletta Bio

Biotechnology

We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.

Symbol

CABA

Price Range
$14.00 - $16.00

Final Shares
5,800,000

Anticipated Date
October 25, 2019

Underwriters
MORGAN STANLEY & CO. LLC,COWEN AND COMPANY, LLC

This offering is no longer available

To view the prospectus for Cabaletta Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253